Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
The New England Journal of Medicine
|
December 4, 2003
Enfuvirtide for prophylaxis against HIV infection
Lise Cuzin, Muriel Alvarez
The Lancet. HIV
|
June 2, 2024
Reducing time to viral suppression in Europe
Lise Cuzin, Pascal Pugliese
BMJ (Clinical Research Ed.)
|
June 30, 2007
Routine testing to reduce late HIV diagnosis in France
Cyrille Delpierre, Lise Cuzin, France Lert
HIV Medicine
|
November 8, 2021
Letter to the editor
Lise Cuzin, Pierre Delobel, Guillaume Martin-Blondel
AIDS Reviews
|
December 19, 2008
Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Lise Cuzin, Clotilde Allavena, Philippe Morlat, et al.
HIV Clinical Trials
|
December 23, 2011
How long do physicians wait to start antiretroviral treatment in newly diagnosed HIV-infected patients?
Lise Cuzin, Cyrille Delpierre, Yazdan Yazdanpanah, et al.
Sexually Transmitted Infections
|
May 6, 2022
Correspondence on 'Pulmonary endocarditis due to <i>Neisseria gonorrhoeae</i> in a patient living with HIV' by Cabras <i>et al</i>
Ornella Cabras, Jean-Marie Turmel, Andrea Rami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2023
Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009-2019: A Longitudinal Cohort Study
Lise Cuzin, Adeline Morisot, Clotilde Allavena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2007
Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years
Lise Cuzin, Cyrille Delpierre, Stéphane Gerard, et al.
AIDS (London, England)
|
February 19, 2016
Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?
Philippe Flandre, Pascal Pugliese, Clotilde Allavena, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
The New England Journal of Medicine
|
December 4, 2003
Enfuvirtide for prophylaxis against HIV infection
Lise Cuzin, Muriel Alvarez
The Lancet. HIV
|
June 2, 2024
Reducing time to viral suppression in Europe
Lise Cuzin, Pascal Pugliese
BMJ (Clinical Research Ed.)
|
June 30, 2007
Routine testing to reduce late HIV diagnosis in France
Cyrille Delpierre, Lise Cuzin, France Lert
HIV Medicine
|
November 8, 2021
Letter to the editor
Lise Cuzin, Pierre Delobel, Guillaume Martin-Blondel
AIDS Reviews
|
December 19, 2008
Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Lise Cuzin, Clotilde Allavena, Philippe Morlat, et al.
HIV Clinical Trials
|
December 23, 2011
How long do physicians wait to start antiretroviral treatment in newly diagnosed HIV-infected patients?
Lise Cuzin, Cyrille Delpierre, Yazdan Yazdanpanah, et al.
Sexually Transmitted Infections
|
May 6, 2022
Correspondence on 'Pulmonary endocarditis due to <i>Neisseria gonorrhoeae</i> in a patient living with HIV' by Cabras <i>et al</i>
Ornella Cabras, Jean-Marie Turmel, Andrea Rami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2023
Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009-2019: A Longitudinal Cohort Study
Lise Cuzin, Adeline Morisot, Clotilde Allavena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2007
Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years
Lise Cuzin, Cyrille Delpierre, Stéphane Gerard, et al.
AIDS (London, England)
|
February 19, 2016
Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?
Philippe Flandre, Pascal Pugliese, Clotilde Allavena, et al.
Page
of 8